Abstract:Osteoporosis, a systemic bone disorder, is characterized by diminished bone mass and disruption of bone tissue microarchitecture, leading to heightened bone fragility and vulnerability to fractures [1]. Disturbingly, recent findings indicate a significant surge in osteoporosis prevalence among postmenopausal women and individuals aged over 70 [2,3]. Clinically, postmenopausal osteoporosis (PMOP) escalates the risk of both asymptomatic vertebral compression fractures and symptomatic fractures, encompassing the wrist or hip [4]. Although Dual-energy X-ray Absorptiometry (DXA) currently stands as the gold standard for osteoporosis diagnosis [5], its high costs and radiation exposure pose notable drawbacks. In light of this, our study harnesses Olink proteomics to identify potential biomarkers for the diagnosis, early prevention, and treatment of PMOP. Employing the diagnostic criteria outlined in the 2022 edition of the Guidelines for Diagnosis and Treatment of Primary Osteoporosis [6] and the 2018 edition of the Chinese Quantitative CT (QCT) Diagnostic Guidelines for Osteoporosis [7], Postmenopausal women were classified into three groups based on dual-energy X-ray absorptiometry and Quantitative Computed Tomography (QCT) results: the osteoporosis group (T value=-2.5) consisting of 24 cases, the bone mass loss group (-2.5<-1.0) with 20 cases, and the control group (T value=-1.0) comprising 16 cases. Fasting serum samples were collected and subjected to biochemical analysis. Using Olink proteomics technology, based on its core protein detection patent - Proximity Extension Assay (PEA), multiple protein expression values were accurately detected from each sample. The protein expression values were standardized using IPC (Inter-plate Control) Normalization. Samples and proteins were grouped and classified based on similarity to generate a clustering heatmap. Hierarchical clustering analysis of the heatmap (depicted in Figure 1A-C) revealed a consis tent trend in the expression of differentially expressed proteins within each group. However, there were significant variations in the expression of these proteins among the different groups. Illustrated in the volcano plot of differentially expressed proteins among the groups (shown in Figure 2A-C), To validate the proteomic data, six differentially expressed proteins exhibiting substantial alterations were selected, and box plots were generated (Figure 3A-F).Further, subjects from the osteopenia and osteoporosis groups were combined (Group 2-3) and compared with the control group (Group 1) characterized by normal bone mass. Notably, in Group 2-3, the expression of ADAM-TS13, ANGPT1, and CTRC increased, while the expression of IL6, IDUA, and TRAIL-R2 decreased. Their trends of variation were consistent with the outcomes of proteomic analysis. To identify proteins that have similar or related functions, we employed the STRING online analysis tool (http://www.string-db.org/) to construct an intricate Protein-Protein Interaction (PPI) network. We then computed the Pearson correlation coefficient for pairs of such proteins and created the clustering heat map shown in Figure 4 to analyze the correlations between the different proteins. Our investigation revealed 61 differentially expressed proteins among the study samples. Differential protein Venn analysis was conducted for the comparisons between osteopenia (M) and normal bone mass (C) groups (Figure 5A), osteoporosis (S) and normal bone mass (C) groups (Figure 5B), as well as osteoporosis (S) and osteopenia (M) groups (Figure 5C). The outcomes, illustrated in Figure 5. Through ROC curve analysis, we identified 12 candidate molecules with potential relevance to PMOP: CD40-L, PGF, IL-1ra, PRSS27, TF, SCF, KIM1, PRELP, HO-1, GDF-2, MMP12, and CD4. Correspondingly, ROC curves were generated for these twelve distinct proteins. As depicted in Figure B, the AUC was 1, indicating a comprehensive discriminatory ability. Our findings underscore the unique protein profiles and their potential diagnostic significance in distinguishing different osteoporosis groups. Concurrent assessment of plasma biomarkers shows promise in facilitating early detection and prognosis of PMOP. Data availability statement The data that support the findings of this study are available from the corresponding author upon reasonable. Funding statement The study was funded by Beijing Jishuitan Hospital Nova Program XKXX202212; This study was supported by the Beijing Municipal Health Commission (BJRITO-RDP-2023). Conflict of Interest The authors declare that they have no conflict of interest.

Comparative studies of genetic and phenotypic associations for 2,168 plasma proteins measured by two affinity-based platforms in 4,000 Chinese adults

An exposome-wide assessment of 6600 SomaScan proteins with non-genetic factors in Chinese adults

An exposome-wide investigation of 2923 Olink proteins with non-genetic factors in Chinese adults

Ancestry Diversity in the Genetic Determinants of the Human Plasma Proteome and Associated New Drug Targets

Proteome-wide Assessment of 10,000 Plasma Proteins with Age-Related Diseases and Multi-Morbidity in a Chinese Population

Plasma proteomic comparisons change as coverage expands for SomaLogic and Olink

Stability and reproducibility of proteomic profiles in epidemiological studies: Comparing the Olink and SOMAscan platforms

Conventional and genetic associations of adiposity with 1463 proteins in relatively lean Chinese adults

Plasma proteomic associations with genetics and health in the UK Biobank

Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes

Risk prediction of ischemic heart disease using plasma proteomics, conventional risk factors and polygenic scores in Chinese and European adults

Proteo-genomic analyses in relatively lean Chinese adults identify proteins and pathways that affect general and central adiposity levels

Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility

Association Between Asthma and Depressive Symptoms: Evidence from the China Health and Retirement Longitudinal Survey (CHARLS)

Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease

Large scale proteomic studies create novel privacy considerations

Atlas of the Plasma Proteome in Health and Disease in 53,026 Adults

Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases

Blood protein assessment of leading incident diseases and mortality in the UK Biobank

Proteogenomic analysis integrated with electronic health records data reveals disease-associated variants in Black Americans

Rare variant associations with plasma protein levels in the UK Biobank